Sakurai, Fuminori

Adenovirus vector-based vaccine for infectious diseases

Sakurai, F., Tachibana, M., & Mizuguchi, H. (2022) · Drug Metabolism and Pharmacokinetics

Virus-based gene therapy researchImmunotherapy and Immune Responses

Cited by 148

Efficient gene transfer into human CD34+ cells by an adenovirus type 35 vector

Sakurai, F., Mizuguchi, H., & Hayakawa, T. (2003) · Gene Therapy

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 88

Direct conversion of human fibroblasts into hepatocyte-like cells by ATF5, PROX1, FOXA2, FOXA3, and HNF4A transduction

Nakamori, D., Akamine, H., Takayama, K., Sakurai, F., & Mizuguchi, H. (2017) · Scientific Reports

Pluripotent Stem Cells ResearchLiver physiology and pathology

Cited by 64

Comparison of Gene Expression Efficiency and Innate Immune Response Induced by Ad Vector and Lipoplex

Sakurai, H., Sakurai, F., Kawabata, K., Sasaki, T., Koizumi, N., Huang, H., Tashiro, K., Kurachi, S., Nakagawa, S., & Mizuguchi, H. (2007) · Journal of Controlled Release

RNA Interference and Gene DeliveryVirus-based gene therapy research

Cited by 40